Skip to main content
. 2020 May 30;45(9):1482–1489. doi: 10.1038/s41386-020-0724-x

Fig. 1. Maps of the molecular templates of the dopamine and noradrenaline transporters (DAT and NET) and their respective target-enriched fMRI maps.

Fig. 1

The fMRI maps are averaged across subjects for the placebo and methylphenidate (MPH) conditions. The occipital areas were masked out for both molecular atlases as they were used as reference regions for the quantification of the molecular data in the kinetic models for the radioligands. For more details on the molecular templates, please refer to [45, 46].